ʻO Cidofovir Anhydrous 113852-37-2 Antiviral
Uku:T/T, L/C
Kumu Huahana:Kina
Awa moku:Pekina/Shanghai/Hangzhou
Hiki ke hana:1kg / mahina
Kauoha(MOQ):1g
Ka manawa o waena o ka hoʻomaka a i ka wā pau:3 Nā lā hana
Kūlana mālama:Mālama ʻia ma kahi maloʻo a hoʻopaʻa ʻia, hoʻopaʻa ʻia a mālama ʻia mai ka mālamalama.
Mea paʻa:hue, ʻōmole
Nui pūʻolo:1g/puʻu, 5/puʻu, 10g/puʻu, 50g/puʻu, 500g/puʻu
ʻIke palekana:UN 2811 6.1/ PG 3
Hoʻolauna
ʻO Cidofovir dihydrate ka dihydrate o ke ʻano anhydrous o cidofovir.ʻO kahi analogue nucleoside, he antiviral injectable i hoʻohana ʻia no ka mālama ʻana i ka cytomegalovirus (CMV) retinitis i nā maʻi AIDS.He kuleana kona ma ke ʻano he lāʻau antiviral a me kahi mea antineoplastic.
Hōʻike (ma ka hale maʻamau)
| Nā mea | Nā kikoʻī |
| Ka nana aku | ʻO ke keʻokeʻo a i ka pauka crystalline keʻokeʻo |
| ʻIkepili
| ʻIkepili Infrared |
| ʻO ka manawa paʻa o ka hāʻina Laʻana e pili ana i ka hopena maʻamau, e like me ka loaʻa ʻana ma ka Assay. | |
| Koena ma ka Ignition | ≤0.5% |
| ʻO nā mea haumia kino
| cidofovir diol analoga≤0.15% |
| Cidofovir pili pūhui A ≤0.15% | |
| cidofovir pili pūhui B ≤0.15% | |
| ʻO ka cidofovir uracil analogb ≤0.15% | |
| ʻO Bromocidofovirc≤0.15% | |
| ʻO kēlā me kēia kanaka i hōʻike ʻole ʻia i ka haumia ≤0.10% | |
| Huina haumia ≤1.0% | |
| Maemae Enantiomeric | ≤1.0% |
| Nā ho'āʻo helu microbiala me nā hoʻāʻo ʻana no nā microorganism i koho ʻia | ʻO ka nui o ka helu bacteria aerobic he NMT 102cfu/g.ʻO ka nui o ka helu ʻana i nā mea hū a me nā mea hū he NMT 101cfu/g. |
| Hooholo Wai | ≤0.5% |
| pH | 2.5-4.5 |
| Hoʻāʻo | 98.0% -102.0%, ma ke kumu anhydrous |
